ReviewJournal of cardiovascular electrophysiology2026
Artificial Intelligence Enabled Noninvasive Mapping of Cardiac Arrhythmia Origins Using the 12-Lead Electrocardiogram.
Review in Journal of cardiovascular electrophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence (AI) is reshaping cardiac electrophysiology by extracting information from electrocardiograms that exceeds human visual interpretation. While most AI applications have focused on arrhythmia detection and risk stratification, a newer and more targeted use case is emerging: noninvasive localisation of arrhythmia origins from a standard 12-lead electrocardiogram (ECG). This review examines the current evidence supporting AI-driven ECG-based localisation of arrhythmogenic foci, with an emphasis on accessory pathways and idiopathic ventricular arrhythmias. Recent machine learning and deep learning models have demonstrated high accuracy in predicting anatomical sites of origin. These advances suggest that AI can capture subtle spatiotemporal electrical patterns that correlate with specific cardiac regions, offering a form of virtual pre-procedural mapping. Early clinical data indicate that AI-informed localisation may shorten procedure duration, reduce fluoroscopy exposure, and improve ablation efficiency without compromising safety. The review also discusses key technical innovations, including convolutional neural networks, multimodal data integration, and strategies to enhance model generalisability and interpretability. Important challenges remain, particularly around external validation, data quality, clinician trust, and workflow integration. Nevertheless, AI-driven ECG localisation represents a conceptual shift from diagnostic support toward therapeutic guidance in electrophysiology. As validation studies and translational research advance, this technology has the potential to transform pre-procedural planning and intraprocedural decision-making, thereby making arrhythmia ablation more precise, efficient, and accessible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.